Experimental infection and protection against ... - TI Pharma
Experimental infection and protection against ... - TI Pharma
Experimental infection and protection against ... - TI Pharma
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
144 Chapter 7<br />
with either the NF54 strain or its clone 3D7 (~1300 volunteers [4, 27]) as<br />
opposed to only 42 volunteers challenged with strain 7G8 of South American<br />
origin [7, 8, 27]. 3D7 is derived from NF54 <strong>and</strong> cannot be distinguished from<br />
NF54 by drug sensitivity testing, simple genetic markers, or microsatellite<br />
mapping (Sim et al., unpublished). Thus, clinical trials with more genetically<br />
distinct parasite strains including 7G8 or NF135.C10 will be important to<br />
complement current knowledge on heterologous Pf strains. Parasitological <strong>and</strong><br />
clinical findings after CHMI with NF54 or 3D7 were recently compared in two<br />
meta-analyses (Roestenberg et al. PLoS One, in press)[28]. Here we show that<br />
clinical signs <strong>and</strong> symptoms induced by NF135.C10 or NF54 do not show any<br />
differences in successfully infected volunteers. We found slight differences in<br />
infectivity of the parasites; in these small groups of volunteers, NF135.C10<br />
showed a marginally shorter prepatent period, but parasite kinetics of both<br />
NF135.C10 <strong>and</strong> NF54 were both within the limits of historical NF54 controls.<br />
Notably, not all volunteers exposed to NF54 infected mosquitoes became<br />
parasitemic, as assessed by both microscopy <strong>and</strong> qPCR in contrast to 22 previous<br />
CHMI trials infecting 128 naive volunteers with NF54 parasites (Roestenberg et<br />
al. PLoS One, in press). Unsuccessful <strong>infection</strong> after bites of five mosquitoes has<br />
been described previously for 3D7 [29, 30]. Although the exact reason is unclear,<br />
this might due to the unusual low NF135.C10 <strong>and</strong> NF54 oocyst <strong>and</strong> sporozoite<br />
counts per mosquito obtained for this trial compared to our routinely obtained<br />
counts (table 1). A technical disturbance in our cultures, leading to suboptimal<br />
culture circumstances prior to this study was most likely the reason for this<br />
relatively low mosquito <strong>infection</strong> with both strains. However, a formal<br />
relationship between sporozoite counts <strong>and</strong> mosquito infectivity has never been<br />
established [31] <strong>and</strong> only small percentages of sporozoites in salivary gl<strong>and</strong>s are<br />
injected during a blood meal of a mosquito [32-34]. Surprisingly, all three<br />
unsuccessfully infected volunteers reported AEs that were considered possibly,<br />
probably, or definitely related to the trial procedures. Symptoms reported by<br />
these volunteers might have been the result of over-reporting in an intense<br />
follow-up schedule, concurring with our findings from a previous study, in which<br />
volunteers reported malaria-related symptoms after exposure to bites of only<br />
uninfected mosquitoes [35].<br />
Previously, we reported sustained IFNγ re-call responses in vitro in both αβ-T<br />
cells <strong>and</strong> γδ-T cells upon homologous PfRBC re-stimulation with NF54 asexual<br />
stage parasites after a single CHMI, suggestive of cross talk between innate <strong>and</strong><br />
adaptive compartments with induction of memory [36, 37]. Here we show<br />
similar kinetics <strong>and</strong> composition of IFNγ responses upon homologous Pf54 <strong>and</strong>